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Two Homologous EF-G Proteins from Pseudomonas
aeruginosa Exhibit Distinct Functions
Stephanie O. Palmer, Edna Y. Rangel, Yanmei Hu, Alexis T. Tran, James M. Bullard*
The University of Texas-Pan American, Edinburg, Texas, United States of America
Abstract
Genes encoding two proteins corresponding to elongation factor G (EF-G) were cloned from Pseudomonas
aeruginosa. The proteins encoded by these genes are both members of the EFG I subfamily. The gene encoding one
of the forms of EF-G is located in the str operon and the resulting protein is referred to as EF-G1A while the gene
encoding the other form of EF-G is located in another part of the genome and the resulting protein is referred to as
EF-G1B. These proteins were expressed and purified to 98% homogeneity. Sequence analysis indicated the two
proteins are 90/84% similar/identical. In other organisms containing multiple forms of EF-G a lower degree of
similarity is seen. When assayed in a poly(U)-directed poly-phenylalanine translation system, EF-G1B was 75-fold
more active than EF-G1A. EF-G1A pre-incubate with ribosomes in the presence of the ribosome recycling factor
(RRF) decreased polymerization of poly-phenylalanine upon addition of EF-G1B in poly(U)-directed translation
suggesting a role for EF-G1A in uncoupling of the ribosome into its constituent subunits. Both forms of P. aeruginosa
EF-G were active in ribosome dependent GTPase activity. The kinetic parameters (KM) for the interaction of EF-G1A
and EF-G1B with GTP were 85 and 70 μM, respectively. However, EF-G1B exhibited a 5-fold greater turnover
number (observed kcat) for the hydrolysis of GTP than EF-G1A; 0.2 s-1 vs. 0.04 s-1. These values resulted in specificity
constants (kcatobs/KM) for EF-G1A and EF-G1B of 0.5 x 103 s-1 M-1 and 3.0 x 103 s-1 M-1, respectively. The antibiotic
fusidic acid (FA) completely inhibited poly(U)-dependent protein synthesis containing P. aeruginosa EF-G1B, but the
same protein synthesis system containing EF-G1A was not affected. Likewise, the activity of EF-G1B in ribosome
dependent GTPase assays was completely inhibited by FA, while the activity of EF-G1A was not affected.
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Introduction
EF-G is a member of the GTPase superfamily and functions
in ribosome-dependent hydrolysis of GTP [1,2,3]. Early
biochemical evidence indicated that EF-G is a multi-domain
GTPase [4,5], an observation which has been confirmed by
crystallographic data [6,7]. During protein synthesis, EF-G is
involved in two distinct steps: elongation and ribosome
recycling. During the elongation step, EF-G binds the ribosome
and promotes the movement of tRNA and mRNA relative to the
ribosome [8,9]. The relative shift of the mRNA is by a distance
of one codon and the peptidyl- and deacylated-tRNAs are
shifted from the pre-translocational to the post-translocational
sites [9,10]. During the recycling step, EF-G acts in concert
with the ribosome recycling factor (RRF) to effect the
disassociation of the ribosome into its individual subunits
[11,12].
EF-G was thought to exist exclusively in a single form as a
bi-functional protein until recently when two genes (hEFG1 and
hEFG2) encoding two different forms of EF-G were discovered
in mammalian mitochondria. Both of these were chromosomal
genes encoding mitochondrial EF-G proteins: EF-G1mt and EF-
G2mt [13,14]. EF-G1mt has since been shown to be functional in
the translocation step of protein synthesis [14]. EF-G2mt lacks
the ability to catalyze the translocation step in protein synthesis
but in the presence of RRF can facilitate disassembly of the
ribosome during the recycling event [15]. Analysis of 191
bacterial genomes in a study of ribosomal associated GTPases
resulted in the identification of multiple forms of EF-G in up to
30% of the bacterial strains analyzed [16]. The second form of
EF-G (EF-G2) has been isolated from three organisms and
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analyzed for activity. EF-G2 from Thermus thermophilus shows
ribosome dependent GTPase activity, with little GTPase activity
in the absence of ribosomes. It has a low level of activity in
poly(U)-dependent protein synthesis but its role in ribosome
recycling remains to be elucidated [17]. EF-G2 isolated from
Mycobacterium smegmatis was assayed for ribosome-
dependent GTPase activity and none was observed, indicating
a lack of ability to function in either of the roles of EF-G under
the conditions studied [18]. Only in Borrelia burgdorferi was the
activity of both forms of EF-G studied in depth [19]. B.
burgdorferi EF-G1 was found exclusively to act in translocation
while EF-G2 was shown to function solely in ribosome
recycling.
Pseudomonas aeruginosa is an opportunistic bacterial
pathogen and the causative agent in a wide range of infections,
including bacteremia, urinary tract infections, burn wound
infections, and pulmonary infections in patients on respirators.
A particularly serious medical problem caused by P.
aeruginosa is chronic lung infection associated with cystic
fibrosis [20]. In an attempt to better understand protein
synthesis as it occurs in P. aeruginosa, we have cloned and
over-expressed two forms of EF-G present in P. aeruginosa.
The proteins encoded by these genes are both members of the
EFG I subfamily [21]. The gene encoding one of the forms of
EF-G is located in the str operon and the resulting protein is
referred to as EF-G1A while the gene encoding the other form
of EF-G is located in another part of the genome and the
resulting protein is referred to as EF-G1B. Unlike multiple forms
of EF-G from other organisms in which the amino acid
sequence exhibits a low level of similarity, the amino acid
sequence of the two forms of EF-G from P. aeruginosa are
highly conserved. In this study, we compared the amino acid
sequence of each of the EF-G molecules from P. aeruginosa
and how they relate to homologous proteins from other
organisms. We then showed ribosome-dependent GTPase
activity, functionality in protein synthesis and the effect of
fusidic acid (FA) on both forms of P. aeruginosa EF-G.
Materials and Methods
Materials
Oligonucleotides were from Integrated DNA Technologies
(Coralville, IA). All other chemicals were obtained from either
Sigma Aldrich (St. Louis, MO) or Fisher Scientific (Pittsburg,
PA). Ribosomes from early log phase growths of P. aeruginosa
strain PA01 were prepared in the laboratory of Walter Hill at the
University of Montana (Missoula, MT) as previously described
[22]. DNA sequencing was at the Howard Hughes Medical
Institute (HHMI) laboratory at The University of Texas – Pan
American. The plasmid pQE60-RRF(C-His) containing the
gene encoding the E. coli ribosome recycling factor (RRF) was
a kind gift from Dr. Nono Tomita-Takeuchi at the University of
Tokyo (Kashiwa, Chiba, Japan).
Gel Electrophoresis and Protein Analysis
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis
(SDS-PAGE) was performed using 4 to12% polyacrylamide
precast gels (Biorad). Benchmark unstained protein molecular
weight markers were from Invitrogen (Madison, WI). Protein
concentrations were determined by the method of Bradford [23]
using Coomassie Protein Assay Reagents (Thermo Scientific)
and bovine serum albumin as the standard.
Cloning and Purification of Two Forms of P. aeruginosa
EF-G
Genes encoding both forms of EF-G were amplified by PCR
(Bio-Rad MJ Mini Thermo Cycler) from P. aeruginosa PAO1
(ATCC) genomic DNA. EF-G1A was amplified using the
forward primer (5’-ctgagctagcgctcgcaccactcccat-3’) and the
reverse primer (5’-gactaagcttcatcagcggccctgcct-3’). EF-G1B
was amplified using the forward primer (5’-
ctgagctagcgcccgtactacacccatca-3’) and the reverse primer (5’-
gactaagcttatcaaccttgttttttaaccagc-3’). The correct DNA
sequence of PCR products was confirmed by DNA sequencing
(Howard Hughes Medical Institute (HHMI) laboratory at The
University of Texas – Pan American). The PCR products were
inserted between the NheI/HindIII restriction sites in a
pET-28b(+) plasmid (Novagen) and transformed into E. coli
Rosetta™ 2(DE3) Singles™ Competent Cells (Novagen). This
process placed the genes downstream of a sequence encoding
six histidine residues.
Cultures were grown in F-medium (yeast extract,14 g/L,
tryptone, 8 g/L, potassium phosphate-dibasic, 12 g/L,
potassium phosphate-monobasic, 1.2 g/L and 1% glucose)
containing 25 μg/ml of kanamycin and 75 μg/ml of
chloramphenicol at 37 °C. Expression of the target proteins
was induced at an optical density (A600) of 0.6 by the addition of
isopropyl β-D-1-thiogalactopyranoside (IPTG) to 0.25 mM.
Growth of the bacterial culture was continued for 3 h post
induction and the bacteria were harvested by centrifugation
(4000 x g, 60 min, 4 °C). The cells were lysed and Fraction I
lysate was prepared as previously described [24]. Both forms
of EF-G were precipitated between 45 and 60% saturation of
ammonium sulfate and the precipitated protein was collected
by centrifugation (23,000 x g, 60 min, 4 °C). Both forms of EF-
G were further purified to more than 98% homogeneity using
nickel-nitrilotriacetic acid (NTA) affinity chromatography
(Perfect Pro, 5 Prime) followed by dialysis (two times) against a
buffer containing: 20 mM Hepes-KOH (pH 7.0), 40 mM KCl, 1
mM MgCl2, 0.1 mM EDTA, 10 % glycerol. Purified proteins
were fast frozen in liquid nitrogen and stored at -80 °C.
Assays
Assays to determine the ribosome-dependent GTPase
activity of EF-G were carried out in 50 μl reactions containing:
50 mM Tris-HCl, (pH 7.5), 10 mM MgCl2, 70 mM NH4Cl, 1 mM
dithiothreitol (DTT) and 1.8 mM GTP. EF-G1A and EF-G1B
concentrations were held constant at 1.0 and 0.3 μM in assays
in which P. aeruginosa ribosomes were titrated and ribosomes
were held constant at 0.4 μM in assays in which EF-G was
titrated. Velocity assays contained indicated amounts of GTP
and assays were stopped each min between 1 and 6 min.
Assays were stopped by the addition of 150 μl of 50 mM
ethylenediaminetetraacetic acid (EDTA). The amount of
GTPase activity was determined by measurement of the
amount of Pi liberated using a colorimetric GTPase assay kit
Two Forms of EF-G from Pseudomonas aeruginosa
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(Novus Biologicals) per manufacturer’s directions. Fusidic acid
(FA) effects were determined using the same assays but
containing from 4 to 250 μM FA.
Protein synthesis assays were carried out in 50 μl reactions
containing: 50 mM Tris-HCl, (pH 7.5), 10 mM MgCl2, 25 mM
KCl, 4 mM phosphoenolpyruvate (PEP), 0.025 U/ml pyruvate
kinase (PK), 1.5 mM ATP, 0.5 mM GTP, 40 μM
[3H]phenylalanine (75 cpm/pmol), 0.3 mg/ml poly(U) RNA, 0.03
mM spermine, 1 mM DTT, 0.05 μM P. aeruginosa Elongation
Factor-Ts (EF-Ts), 1.0 μM P. aeruginosa Elongation Factor-Tu
(EF-Tu), 0.1 μM P. aeruginosa phenylalanyl-tRNA synthetase
(PheRS), 0.2 μM P. aeruginosa ribosomes and the indicated
amounts of EF-G1A or EF-G1B. Reactions were started by the
addition of E. coli tRNA to a final concentration of 0.5 μM
tRNAPhe and continued for 1 h at 37 °C. Reactions were
stopped by the addition of 2 ml 10% trichloroacetic acid (TCA)
and filtered through glass fiber filters (Whatman) as previously
described [25]. Retention of [3H]Phe represents the amount of
poly-phenylalanine, poly(Phe), synthesized. The effects of FA
on protein synthesis were determined using the same assays
but contained from 4 to 250 μM FA. In these assays, the
concentration of EF-G1A and EF-G1B were 1 μM and 0.2 μM,
respectively. Assays to determine the effect of RRF on the
activity of EF-G1B were the same as described above, with
RRF titrated into the assay between 0.2 and 6.4 μM. Assays to
determine the ability of EF-G1A/RRF to affect the activity of
EF-G1B contained 0.2 μM EF-G1B, 1 μM EF-G1A and 2 μM
RRF. In these reactions EF-G1A and/or RRF were pre-
incubated in the reaction mix at 37 °C for 5 min, EF-G1B was
then added and incubation was continued for 1 h.
Results
Sequence Analysis
EF-G is a protein with a molecular mass of approximately 77
kDa. The crystal structure for EF-G from T. thermophilus has
been solved bound to GDP and in the nucleotide free form; it
appears to be an elongated protein composed of five structural
domains [6,7]. More recently, the structure of P. aeruginosa
EF-G1 was determined at 2.9 Å [26] and the structure was
shown to be similar to that of T. thermophilus EF-G1. The
structure of EF-G2 from T. thermophilus has also been
determined and is similar to the structure to EF-G1 even
though the sequence homology is only 30% [17]. Other
organisms studied also indicate that there is only a modest
level of overall amino acid sequence conservation between EF-
G1 and EF-G2 proteins from the same organism (Table 1). In
Table 1, the sequence identity of EF-G1 and EF-G2 from the
same organism ranges from 29-56 % and the sequence
similarity ranges from 44-68 %. Unlike the homologs shown in
Table 1, the two EF-G-like proteins from P. aeruginosa (EF-
G1A and EF-G1B) have a much higher level of amino acid
sequence conservation; with the amino acid sequences being
84% identical and 90% similar (Figure 1). This is a much higher
level of sequence conservation than observed when EF-G1
from different organisms are compared to each other and is
similar to that observed when EF-G1 from different strains of
the same bacteria are compared (data not shown). In the
phylum Proteobacteria only two bacteria that were analyzed
(Bordetella bronchiseptica and Burkholderia rhizoxinica)
contained two EF-G molecules that contained a high level of
amino acid sequence conservation. When P. aeruginosa EF-
G1A and EF-G1B were compared to the four homologs from
these two bacteria a high level of homology was observed in
which the similarity only varied from 76 to 81% (Table 2). The
EF-G molecules from Bordetella bronchiseptica and
Burkholderia rhizoxinica were slightly more homologous to
each other than either was with P. aeruginosa EF-G proteins,
with the similarity only varying between 86 to 91%. This closer
homology might be expected as both of these bacteria belong
to the beta-subdivision of the Proteobacteria phylum while P.
aeruginosa is a member of the gamma-subdivision.
When P. aeruginosa EF-G1A and EF-G1B were compared
with EF-G1 and EF-G2 from other organisms, a wide variation
in the amino acid sequence similarity was observed (Table 2).
A higher degree of similarity was observed when P. aeruginosa
EF-G1A and EF-G1B were compared with EF-G from
organisms containing only one form of EF-G than with
organisms containing multiple forms of EF-G. When compared
with other bacteria having distinct EF-G1 and EF-G2 proteins,
both P. aeruginosa EF-G1A and EF-G1B were more similar to
EF-G1 than with EF-G2 (Table 2).
In a comparison of EF-G1A and EF-G1B, the functional
regions (P-loop, switch I and switch II regions) of domain I are
strictly conserved with only one residue variation from a
methionine to a tyrosine (Figure 1). The five typical motifs (G1-
G5) for GTP recognition [2] are also strictly conserved between
EF-G1A and EF-G1B. EF-G proteins contain a region within
the G-domain termed the G’ insert for which the functional
significance is not well understood. It has been speculated that
this region may be an internal guanine nucleotide exchange
factor (GEF) [27], or possibly a region that specifically functions
in ribosome binding [28]. The G’ insert is highly conserved
between EF-G1A and EF-G1B, with only modest amino acid
variations observed (Figure 1). In domain IV, at position 529
there is a five amino acid insert (KGNIT) observed in EF-G1A
that is not present in EF-G1B. Results from alignments with all
homologs analyzed indicate that three of these amino acids (N,
I andT) are only present in P. aeruginosa EF-G1A (data not
shown). These three residues are located in a loop region in
domain IV and would therefore probably not affect function.
The only region of lower sequence similarity is the region of
domain IV at the C-terminus of the protein. This region contains
the highest degree of divergence between EF-G1A and EF-
G1B; however, the variations seen in these amino acids are
moderate. In the structure of EF-G1 (EF-G1A) from P.
aeruginosa this region forms an α-helix and is detached from
the body of the protein [26].
Fusidic acid inhibits protein synthesis by trapping EF-G in the
post-translocation step during elongation [29,30]. Mutations
conferring resistance to FA have been mapped in EF-G from T.
thermophilus [31,32], S. typhimurium [33] and S. aureus [34].
The positions that these mutations map to in EF-G from P.
aeruginosa are shown in Figure 1. In the approximately forty
sites in which mutations have been identified, all but two are
strictly conserved between EF-G1A and EF-G1B, and these
Two Forms of EF-G from Pseudomonas aeruginosa
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two sites vary from a Ser to Cys at position 115 (EF-G1B
numbering) and from an Ala to Val at position 140 (Figure 1).
None of the amino acid sequence differences observed would
be expected to affect the function of the proteins significantly.
Overall, from the amino acid sequence analysis and
comparisons with EF-G from other organisms, the
differentiation of the roles of EF-G1A and EF-G1B cannot be
discerned.
GTPase Activity and Inhibition by Fusidic Acid
Two forms of EF-G from P. aeruginosa were cloned and
expressed. The purification yielded both forms of EF-G in
preparations that were greater than 98% homogeneous (Figure
Figure 1.  An alignment of EF-G1A and EF-G1B from P. aeruginosa.  The protein sequences were downloaded from the
National Center for Biotechnology Information (NCBI). The accession numbers for the two sequences are AAG05459 for EF-G1B
and AAG07654 for EF-G1A. Sequence alignments were performed using Vector NTI Advance (TM) 11.0 (Invitrogen). Domains are
designated with solid arrows and the G’ insert is designated with dotted arrows. Resistance mutations induced by fusidic acid at
conserved amino acid residues are shown as closed circles (●) and mutations at invariant residues are shown as open circles (o).
The amino acid representing the Walker B box is shown as (▼).
doi: 10.1371/journal.pone.0080252.g001
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2). GTPase activities of both forms of EF-G were shown to be
dependent on the presence of ribosomes (Figure 3A). Only a
low level of activity was observed in the absence of ribosomes
and as the concentration of ribosomes increased, the level of
GTPase activity increased. A ribosomal concentration of 0.4
μM was selected for downstream assays. When compared, EF-
G1B exhibited approximately a 2-fold higher GTPase activity
than was observed for EF-G1A (Figure 3B). At 0.5 μM (in the
linear region of the plot), EF-G1A and EF-G1B were able to
catalyze hydrolysis of 25 and 50 μM of GTP in 30 min
reactions, respectively. At the inflection point on the titration
curves EF-G1B was observed to have the same activity at 0.3
μM as EF-G1A had at 1.0 μM, therefore these concentrations
were selected for downstream velocity assays at lower GTP
concentrations. Timed assays showed that the GTPase activity
of each form of EF-G was linear out to 30 min (Figure 3C).
To determine the kinetic parameters governing the ribosome
dependent hydrolysis of GTP by the two forms of P. aeruginosa
EF-G, initial velocity assays were carried out at varying
concentrations of GTP (from 25 to 600 μM). The kinetic
parameters KM and Vmax, for the GTPase activity of P.
aeruginosa EF-G1B, were determined from Lineweaver-Burk
analysis to be 71 μM and 3.7 μM/min, respectively (Figure 4).
From these data the observed turnover number (kcatobs) was
calculated to be 0.2 s-1 and the specificity constant (kcat/KM) was
Table 1. Conservation of amino acid sequence of EF-G
isoforms from various organisms.
Organism Amino acid Alignment Accession Number
 (EF-G1/EF-G2) (% similar/identical)  
Borrelia burgdorferi 693/669 (24)1 51/34 YP_005806724/YP_005806873
H. sapiens
(mitochondria) 751/777 (26) 44/32 NP_079272/AAH30612
Mycobacterium
semgmatis 701/731 (30) 47/29
YP_006566130/
YP_890748
Thermus thermophilus 691/658 (33) 46/30 YP_005300/YP_005103
Bdellovibrio
bacteriovorus 701/702 (2) 57/41
YP_007023855/
YP_007021899
Bradyrhizobium sp. 690/673 (17) 62/48 ZZ_10086950/CAL77572
Mesorhizobium sp. 696/683 (13) 47/31 YP_007305968/BAB49654
Methylococcus
capsulatus 698/694 (4) 68/56
AAU_91593/
YP_113063
Shewanella sp. 698/691 (7) 66/53 ABK46440/ABL98792
Vibrio cholera 698/695 (3) 65/53 NP_230015/NP_231972
Pseudomonas
aeruginosa2 702/706 (4) 90/84 AAG05459/AAG07654
1 The number in parenthesis represents the difference in the number of amino
acids.
2 EF-G in P. aeruginosa are shown as EF-G1B/EF-G1A.
doi: 10.1371/journal.pone.0080252.t001
calculated to be 3.0 x 103 s-1 M-1 (Table 3). The same
procedure was used to obtain these parameters for EF-G1A
(Figure 5). The KM and Vmax values were 85 μM and 2.4 μM/
min, respectively, and the kcatobs and kcat/KM for the hydrolysis of
GTP by EF-G1A were 0.04 s-1 and 0.5 x 103 s-1 M-1,
respectively. The KM was observed to be very similar for both
forms of EF-G; however, from these data the observed ability
for the turnover of substrate (kcatobs) of EF-G1B is 5-fold greater
than that of EF-G1A.
To determine the inhibitory effect of the antibiotic fusidic acid
on the GTPase activity of both forms of EF-G, assays were
performed containing FA at concentrations between 5 and 250
μM (Figure 6). The GTPase activity of EF-G1B was inhibited at
the lowest concentration of FA tested and the activity was
completely inhibited at FA concentrations above 30 μM.
Alternatively, the GTPase activity of EF-G1A was not affected
at any concentration of FA up to 250 μM.
Function in Protein Synthesis and Inhibition by Fusidic
Acid
An aminoacylation/translation (A/T) system composed of P.
aeruginosa protein synthesis components has been developed
in our laboratory [35] (Figure 7). To determine the ability of both
Table 2. Comparison of the conservation of amino acid
residues from P. aeruginosa EF-G1A and EF-G1B with







E. coli1 EF-G 80/67 78/67 0905186A
B. burgdorferi EF-G1 59/44 58/43 YP_005806724
B. burgdorferi EF-G2 55/36 55/36 YP_005806873
H. sapiens EF-G1mt 54/39 54/38 NP_079272
H. sapiens EF-G2mt 47/33 47/34 AAH30612
M. smegmatis EF-G1 71/58 70/57 YP_006566130
M. smegmatis EF-G2 45/29 44/28 YP_890748
T. thermophilus EF-G1 75/60 73/58 YP_005300
T. thermophilus EF-G2 51/33 51/32 YP_005103
S. typhimurium EF-G 80/69 79/69 AAL22309
S. aureus EF-G 72/59 71/57 A7WYX4
B. bronchiseptica (707) EF-
G2 79/66 76/64 NP_890794
B. bronchiseptica (700) EF-G 81/67 80/66 CAE30528
B. rhizoxinica (703) EF-G 79/67 77/64 CBW74068
B. rhizoxinica (700) EF-G 79/66 78/66 CBW74549
1 The organisms analyzed are Escherichia coli, Borrelia burgdorferi, Homo
sapiens, Mycobacterium smegmatis, Thermus thermophilus, Salmonella
typhimurium, Staphylococcus aureus, Bordetella bronchiseptica, Burkholderia
rhizoxinica.
2 The EF-G molecules from B. bronchiseptica and B. rhizoxinica could not be
differentiated by sequence alignment and are differentiated here by the number of
amino acids composing the proteins as shown in parenthesis.
doi: 10.1371/journal.pone.0080252.t002
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forms of EF-G to function in protein synthesis, each was tested
for the ability to function in the synthesis of poly(Phe). Each
form of EF-G was titrated into the assay between 0.05 and 0.5
μM (Figure 7). EF-G1B displayed robust activity in polypeptide
synthesis. In contrast, EF-G1A was only observed to have a
Figure 2.  Sodium dodecyl sulfate-polyacrylamide gel
electrophoresis (SDS-PAGE) analysis of purified P.
aeruginosa EF-G1A and EF-G1B.  Samples (1.0 μg) of the P.
aeruginosa EF-G1A and EF-G1B preparations were analyzed
on a 4-20% SDS-PAGE gel and the protein bands were
visualized by staining with Coomassie blue.
doi: 10.1371/journal.pone.0080252.g002
low level of activity. To ascertain the ability of FA to inhibit
elongation, FA was added to protein synthesis assays at
concentrations between 5 and 500 μM (Figure 8). As shown in
Figure 8A, even though the activity of EF-G1A only yields 0.6
μM poly(Phe) in the elongation phase of protein synthesis, the
addition of FA does not appear to affect the activity even at the
highest concentration of FA. The initial drop in activity shown in
Figure 8A is due to the inhibition of background activity, likely
due to small amounts of EF-G1B co-purified with ribosomes.
These results are similar to the lack of effect that FA had on the
GTPase activity of EF-G1A. However, FA has a profound effect
on the ability of EF-G1B to function in protein synthesis (Figure
8B). At the lowest concentration of FA (4 μM) the activity was
reduced by 25% and at the highest concentration of FA the
activity is completely inhibited. These results suggest that EF-
G1B is involved in the elongation phase of protein synthesis
and that EF-G1A is not.
Ability of P. aeruginosa EF-G1A to Function in
Ribosomal Recycling
In mammalian mitochondria the two forms of EF-G were
shown to have different functions. EF-G1mt functions in the
elongation stage of protein synthesis while EF-G2mt in the
presence of RRF functions in ribosomal recycling [14,15]. This
was also shown to be the case in B. burgdorferi where EF-G1
was found to function in translocation while EF-G2 was shown
to function exclusively in recycling [19]. To determine whether
EF-G1A or EF-G1B functions along with RRF in catalyzing the
separation of the two ribosomal subunits, each form of EF-G
was tested in protein synthesis assays in the presence of
increasing amounts of RRF (0.2 to 6.4 μM). Unlike protein
synthesis using a natural messenger RNA, in poly(U) directed
protein synthesis initiation can begin in the presence of tight-
coupled (TC) 70S ribosomes [36]. If ribosomes are dissociated
into the individual subunits the synthesis of poly(Phe) would be
reduced. Likewise, the assay only detects poly(Phe) bound to
ribosomes [37], therefore poly(Phe) synthesized and then
released during the recycling event would not be detected and
the overall activity would be reduced. When EF-G1B was
assayed in this system (Figure 9A), no decrease in the
synthesis of poly-Phe was observed at any concentration of
RRF, indicating that EF-G1B was not able to act with RRF to
recycle or separate the ribosomal subunits. In identical assays,
the low level of activity of EF-G1A in protein synthesis was not
observed to be affected by RRF at any concentration (data not
shown). Figure 9B shows that RRF has no effect on the activity
of either EF-G1A or EF-G1B in protein synthesis. When EF-
G1A is added to the A/T protein synthesis system along with
EF-G1B there is also no decrease in activity detected.
However, when EF-G1A and RRF were pre-incubated with
ribosomes prior to the addition of EF-G1B, protein synthesis
was decreased by 25-30% (Figure 9B). These results indicate
that EF-G1A and RRF act in concert to reduce protein
synthesis. The recycling of the ribosomal subunits decreases
the number of ribosomes available to function in protein
synthesis and is the likely mechanism by which this is
occurring.
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Discussion
We have expressed and characterized two forms of EF-G
from P. aeruginosa. Both forms of P. aeruginosa EF-G appear
to be more similar to homologs from bacteria containing only
one form of EF-G than to those with multiple forms. When
compared with homologs from bacteria containing more than
one EF-G, both forms of P. aeruginosa EF-G appear more
similar to EF-G1 than to EF-G2. Predictions from sequence
analysis indicate that the two forms of the same protein would
function equally well in protein synthesis. The amino acid
residues comprising the primary sequences of the two forms of
P. aeruginosa EF-G are highly conserved (90/84% similar/
identical). Regions of the sequence that have been shown to
be involved in hydrolysis of GTP are almost strictly conserved
between the two forms. This is complemented by our data that
show that the two EF-G molecules can both efficiently
hydrolyze GTP in ribosome dependent reactions. If these
findings are taken together, one could surmise that the two
molecules are indeed different copies of EF-G performing the
same role. This is supported by the fact that the many residues
that have been shown to mutate in conferring resistance to FA
are also almost strictly conserved between the two forms of
EF-G from P. aeruginosa (Figure 1). However, at this point this
line of thinking breaks down. FA traps EF-G in the post-
translocation site on the ribosome after hydrolysis of GTP [29]
and in this state any further GTPase activity stops. From our
data we know that only one form (EF-G1B) of the two EF-G
Figure 3.  GTPase activity of P. aeruginosa EF-G1A and EF-G1B.  Shown are representative GTPase assays of EF-G and
ribosome dependence and a graph showing the linear increase in GTPase activity between 1 and 30 min. Assays are as described
under “Methods and Materials”. A) Activity of EF-G1A and EF-G1B (1.0 and 0.3 μM, respectively) in the presence of varying
concentrations of P. aeruginosa ribosomes. B) GTPase activity of EF-G at varied concentrations in the presence of 0.4 μM
ribosomes. C) GTPase activity at increasing times. EF-G1A and EF-G1B are represented by filled diamonds (♦) and squares (■),
respectively.
doi: 10.1371/journal.pone.0080252.g003
Figure 4.  Determination of kinetic parameters for the GTPase activity of P. aeruginosa EF-G1B.  A: Initial velocities for P.
aeruginosa EF-G1B in GTPase activity reactions were determined at various concentrations of GTP. The concentration of EF-G1B
was held constant at 0.3 μM. The velocities were measured between 1 and 6 min to minimize the chance of measurement of GTP
hydrolysis occurring during mixing but before the beginning of the incubation period. The reactions were at 37 °C. The
concentrations of GTP were: ♦, 25 μM; ■, 50 μM; ▲, 100 μM; +, 200 μM; ●, 400 μM, ×, 600 μM. B: The data from the initial velocity
experiments were used to develop a Lineweaver-Burk plot to determine kinetic parameters for the GTPase activity of P. aeruginosa
EF-G1B.
doi: 10.1371/journal.pone.0080252.g004
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molecules is inhibited by FA. If this is true, the other form (EF-
G1A) of the protein confers resistance to FA. However, if this is
not the case then the form that is not affected by FA (EF-G1A)
is not involved in translocation during the elongation phase of
protein synthesis. Further experimentation indicated that only
one form of the protein (EF-G1B) was functional in poly(Phe)
synthesis (or the elongation phase) and this is the form that is
susceptible to FA. This would weigh against the idea that the
form of EF-G not susceptible to FA (EF-G1A) confers FA
resistance. EF-G along with RRF functions in the disassembly
of the post-termination ribosome [11]. Additional experimental
evidence described here showed that the form of EF-G (EF-
G1A) that is not susceptible to FA in the presence of RRF
reduced the ability to synthesize poly(Phe). This provides
preliminary biochemical evidence that EF-G1A may play a role
in ribosome recycling; however biophysical experimental data
Figure 5.  Determination of kinetic parameters for the GTPase activity of P. aeruginosa EF-G1A.  A: Initial velocities for P.
aeruginosa EF-G1A in GTPase activity reactions were determined at various concentrations of GTP. The concentration of EF-G1A
was held constant at 1.0 μM. The velocities were measured between 1 and 6 min to minimize the chance of measurement of GTP
hydrolysis occurring during mixing but before the beginning of the incubation period. The concentrations of GTP were: ♦, 25 μM; ■,
50 μM; ▲, 100 μM; +, 200 μM; ●, 400 μM, ×, 600 μM. B: The data from the initial velocity experiments were used to develop a
Lineweaver-Burk plot to determine kinetic parameters for the GTPase activity of P. aeruginosa EF-G1A.
doi: 10.1371/journal.pone.0080252.g005
Figure 6.  The effect of fusidic acid on the GTPase activity of P. aeruginosa EF-G1A and EF-G1B.  Representative GTPase
assays of the activity of EF-G1A and EF-G1B in increasing amounts of fusidic acid. The concentration of EF-G1A and EF-G1B were
1.0 and 0.3 μM, respectively, and the concentration of ribosomes was 0.4 μM. FA was added to the assay in concentrations from 4
μM to 250 μM. EF-G1A and EF-G1B are represented by filled diamonds (♦) and squares (■), respectively.
doi: 10.1371/journal.pone.0080252.g006
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would be required to definitively state that this is the case. This
brings us to the conclusion that EF-G1B is the sole translocase
in the elongation phase of protein biosynthesis in P.
aeruginosa.
Evolutionary studies have identified four subfamilies of EFG:
EFG I, spdEFG1, spdEFG2 and EFG II [21]. First, EFG I is
encoded by the fus gene which is located in the str operon
which also contains the genes encoding S12 and S7 ribosomal
proteins along with a tuf gene which encodes EF-Tu (another
protein involved in the elongation phase of protein synthesis).
In many organisms this form of EF-G is the major translocase
involved in protein biosynthesis. Next, the spdEFG subfamilies
are restricted to three taxonomic divisions: Spriochaetes,
Planctomycetes and δ-proteobacteria and to mitochondria [38].
The two subgroups of EF-G found in these three taxonomic
divisions have been shown to have different functions in
mitochondria and in B. burgdorferi [14,15]. Finally, EFG II
proteins are highly divergent in primary sequence and thought
to be a duplication of EFG I early in prokaryotic evolution which
evolved along a different line [38]. P. aeruginosa EF-G1A and
Table 3. The kinetic parameters governing the ribosome
dependent GTPase activity of both forms of P. aeruginosa
EF-G.
EF-G KM kcatobs kcatobs/ KM
 (μM) (s-1) (s-1, M-1)
EF-G1A 85 0.04 0.5 x 103
EF-G1B 70 0.2 3.0 x 103
doi: 10.1371/journal.pone.0080252.t003
EF-G1B are both members of the EFG I subfamily. The
Pseudomonas sp., along with the Burkholderia sp.and
Bordetella sp. are shown to have a second EF-G (located
outside the str operon) that is termed a recent duplication from
EFG I and the genes encoding these proteins are thought to
have been acquired by lateral gene transfer [38]. The authors
from this work [38] indicate that the high identity of these
second EFG I proteins indicates retention of original function.
We have shown here that the original function, at least in the
case of P. aeruginosa, of the two highly conserved proteins has
not been retained. P. aeruginosa EF-G1A is encoded by the
fus gene located in the str operon and appears to function in
ribosome recycling, while EF-G1B, which functions in
translocation, is encoded in a secondary fus like gene (80%
identical) and is located in the opposite side of the genome
from the str operon. Perhaps as suggested for spdEFG1 and 2
[21], the duplication released EF-G from the constraints
inherent to proteins with dual functions allowing each to
become more specialized in distinct singular functions.
The structure of what is referred to as EF-G1 from P.
aeruginosa has recently been solved by groups from Novartis
[26]. This protein was called EF-G1 since it is encoded by the
fusA gene that is located within the str operon. The natural
compound argyrin B was shown to inhibit growth of P.
aeruginosa and when the genome of one mutant was
sequenced a single point mutation in the fusA gene (labeled as
fusA1) was detected. The fusA1 gene was then sequenced
from five additional fusA mutants and at least seven mutations
(P414S, S417L, S459F, P486S, L663Q, T671A, and Y683C)
were detected. There were no details from this work that
indicated that the gene (fusA2) encoding the second EF-G
Figure 7.  The ability of both forms of P. aeruginosa EF-G to function in protein synthesis.  Representative protein synthesis
assays containing increasing concentrations of EF-G1A and EF-G1B. The assays were as described under “Methods and
Materials”. Concentrations of EF-G were as shown and concentrations of ribosomes were held constant at 0.2 μM. EF-G1A and EF-
G1B are represented by filled diamonds (♦) and squares (■), respectively. “Phe Incorporated” represents the amount of
phenylalanine incorporated into peptides during protein synthesis. Background activity (0.5 μM) was subtracted from the assay
containing EF-G.
doi: 10.1371/journal.pone.0080252.g007
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(EFG 2) was sequenced from any other argyrin B resistant
mutants after the initial genome that was screened. From the
work described here, we know that the protein that was labeled
EF-G1 (encoded by fusA1) is the form of EF-G (EF-G1A) that
is not functional in elongation but appears to be involved in
ribosome recycling. Comparison of the protein primary
sequence indicates that the mutated residues identified in
conferring resistance to argyrin B in EF-G1 (EF-G1A) are
conserved in EF-G1B. Also, the residues in EF-G1 (EF-G1A)
shown in the Novartis structure that directly interact with argyrin
B are also conserved in EF-G1B. Another group [39] carried
out a similar set of experiments and identified two additional
mutation sites in the EF-G1 fusA1 gene, at positions Ile457 and
Met685. The amino acids at these two positions are also
conserved in EF-G1B. This group also sequenced the fusA2
gene (encoding EF-G1B) and found no mutations in argyrin B
resistant mutants. The possibility exists that this compound,
like FA, may inhibit the activity of one form of EF-G yet have no
effect on the other form. If this is the case, argyrin B only
inhibits the form of EF-G that may be involved in ribosome
recycling. This study [39] also analyzed the level of mRNA
encoding EF-G1 and EF-G2 from P. aeruginosa that was taken
Figure 8.  The effect of fusidic acid on the activity of P. aeruginosa EF-G in protein synthesis.  Representative assays of the
effect of increasing concentrations of fusidic acid on the ability of EF-G1A and EF-G1B to function in protein synthesis. A) EF-G1A
and B) EF-G1B. The concentration of EF-G1A and EF-G1B were 1.0 and 0.2 μM, respectively, and the concentration of ribosomes
was 0.2 μM. FA was added to the assay in concentrations from 4 μM to 500 μM. EF-G1A and EF-G1B are represented by filled
diamonds (♦) and squares (■), respectively.
doi: 10.1371/journal.pone.0080252.g008
Figure 9.  RRF and EF-G1A function to reduce the synthesis of poly(Phe).  Representative assays depicting the effect of
ribosome release factor (RRF) on the activities of EF-G1A, EF-G1B and a combination of EF-G1A and EF-G1B. A) Assays to
determine the effect of RRF on the activity of EF-G1B were as described under “Methods and Materials”, with RRF titrated into the
assay between 0.2 and 6.4 μM. The concentration of EF-G1B was 0.2 μM. B) Assays to determine the effect of RRF/EF-G1A on the
activity of EF-G1B. The concentration of EF-G1B was the same as in “A” and the concentration of EF-G1A and RRF were 1 and 2
μM, respectively.
doi: 10.1371/journal.pone.0080252.g009
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from clinical isolates. RNA transcripts encoding EF-G1 (EF-
G1A) was observed to be more highly transcribed in clinical
isolates than were transcripts encoding EF-G2 (EF-G1B). The
sources of the clinical isolates were not given. This is contrary
to what would be expected in actively growing cultures. In
growing cultures, if EF-G1B functions exclusively in
translocation and EF-G1A functions exclusively in ribosome
recycling, since there are many more rounds of elongation than
termination events one would expect to find more mRNA
encoding EF-G1B than EF-G1A. However, if the samples were
taken from respiratory passages in cystic fibrosis patients in
which the bacteria form biofilms, a different set of mRNA might
be expected. In biofilm formation the bacteria under goes a
shift in behavior in which large suites of genes are differentially
regulated [40]. In the anaerobic environment of cells making up
the biofilm [41] many cells are in a stationary phase and growth
is minimal therefore levels of mRNA encoding EF-G1B would
be expected to be maintained at a low level.
In this work, we have shown that the two forms of EF-G from
P. aeruginosa, which contain a high level of homology, perform
distinctly different functions during protein biosynthesis. From
an in-depth inspection of the primary amino acid sequences no
viable reason for this was determined. It would be of interest in
future studies to exchange the domains of the two forms of EF-
G and determine which domain is responsible for the variation
of activity as well as which region is responsible for the
resistance to the antibiotic FA.
Acknowledgements
The authors would like to express their gratitude to Dr. Frank
Dean (University of Texas – Pan American) and Dr. Linda
Spremulli (University of North Carolina – Chapel Hill) for their
critical reading of this manuscript.
Author Contributions
Conceived and designed the experiments: JMB SOP EYR YH
ATT. Performed the experiments: SOP EYR YH ATT. Analyzed
the data: JMB SOP EYR YH ATT. Contributed reagents/
materials/analysis tools: JMB. Wrote the manuscript: JMB.
Reviewed manuscript: SOP EYR YH ATT.
References
1. Conway TW, Lipmann F (1964) Characterization of a ribosome-linked
guanosine triphosphatase in Escherichia coli extracts. Proc Natl Acad
Sci U_S_A 52: 1462-1469. doi:10.1073/pnas.52.6.1462. PubMed:
14243519.
2. Bourne HR, Sanders DA, McCormick F (1991) The GTPase
superfamily: conserved structure and molecular mechanism. Nature
349: 117-127. doi:10.1038/349117a0. PubMed: 1898771.
3. Nishizuka Y, Lipmann F (1966) Comparison of guanosine triphosphate
split and polypeptide synthesis with a purified E. coli system. Proc Natl
Acad Sci U_S_A 55: 212-219. doi:10.1073/pnas.55.1.212. PubMed:
4287350.
4. Alakhov YB, Dovgas NV, Motuz LP, Vinokurov LM, Ovchinnikov YA
(1981) The primary structure of the elongation factor G from
Escherichia coli: amino acid sequence of the C-terminal domain. FEBS
Lett 126: 183-186. doi:10.1016/0014-5793(81)80237-2. PubMed:
7016587.
5. De VE, Masullo M, Bocchini V (1986) The elongation factor G carries a
catalytic site for GTP hydrolysis, which is revealed by using 2-propanol
in the absence of ribosomes. J Biol Chem 261: 4445-4450. PubMed:
3007457.
6. Czworkowski J, Wang J, Steitz TA, Moore PB (1994) The crystal
structure of elongation factor G complexed with GDP, at 2.7 Å
resolution. EMBO J 13: 3661-3668. PubMed: 8070396.
7. AEvarsson A, Brazhnikov E, Garber M, Zheltonosova J, Chirgadze Y et
al. (1994) Three-dimensional structure of the ribosomal translocase:
elongation factor G from Thermus thermophilus. EMBO J 13:
3669-3677. PubMed: 8070397.
8. Rodnina MV, Savelsbergh A, Katunin VI, Wintermeyer W (1997)
Hydrolysis of GTP by elongation factor G drives tRNA movement on
the ribosome. Nature 385: 37-41. doi:10.1038/385037a0. PubMed:
8985244.
9. Rodnina MV, Wintermeyer W (2011) The ribosome as a molecular
machine: the mechanism of tRNA-mRNA movement in translocation.
Biochem Soc Trans 39: 658-662. doi:10.1042/BST0390658. PubMed:
21428957.
10. Frank J, Gao H, Sengupta J, Gao N, Taylor DJ (2007) The process of
mRNA-tRNA translocation. Proc Natl Acad Sci U_S_A 104:
19671-19678. doi:10.1073/pnas.0708517104. PubMed: 18003906.
11. Hirashima A, Kaji A (1973) Role of elongation factor G and a protein
factor on the release of ribosomes from messenger ribonucleic acid. J
Biol Chem 248: 7580-7587. PubMed: 4583357.
12. Zavialov AV, Hauryliuk VV, Ehrenberg M (2005) Splitting of the post-
termination ribosome into subunits by the concerted action of RRF and
EF-G. Mol Cell 18: 675-686. doi:10.1016/j.molcel.2005.05.016.
PubMed: 15949442.
13. Hammarsund M, Wilson W, Corcoran M, Merup M, Einhorn S et al.
(2001) Identification and characterization of two novel human
mitochondrial elongation factor genes, hEFG2 and hEFG1,
phylogenetically conserved through evolution. Hum Genet 109:
542-550. doi:10.1007/s00439-001-0610-5. PubMed: 11735030.
14. Bhargava K, Templeton P, Spremulli LL (2004) Expression and
characterization of isoform 1 of human mitochondrial elongation factor
G. Protein Expr Purif 37: 368-376. doi:10.1016/j.pep.2004.06.030.
PubMed: 15358359.
15. Tsuboi M, Morita H, Nozaki Y, Akama K, Ueda T et al. (2009) EF-G2mt
is an exclusive recycling factor in mammalian mitochondrial protein
synthesis. Mol Cell 35: 502-510. doi:10.1016/j.molcel.2009.06.028.
PubMed: 19716793.
16. Margus T, Remm M, Tenson T (2007) Phylogenetic distribution of
translational GTPases in bacteria. BMC Genomics 8: 15-33. doi:
10.1186/1471-2164-8-15. PubMed: 17214893.
17. Connell SR, Takemoto C, Wilson DN, Wang H, Murayama K et al.
(2007) Structural basis for interaction of the ribosome with the switch
regions of GTP-bound elongation factors. Mol Cell 25: 751-764. doi:
10.1016/j.molcel.2007.01.027. PubMed: 17349960.
18. Seshadri A, Samhita L, Gaur R, Malshetty V, Varshney U (2009)
Analysis of the fusA2 locus encoding EFG2 in Mycobacterium
smegmatis. Tuberculosis (Edinb.) 89: 453-464.
19. Suematsu T, Yokobori SI, Morita H, Yoshinari S, Ueda T et al. (2010) A
bacterial elongation factor G homologue exclusively functions in
ribosome recycling in the spirochaete Borrelia burgdorferi. Mol
Microbiol 75: 1445-1454. doi:10.1111/j.1365-2958.2010.07067.x.
PubMed: 20132446.
20. Roussel P, Lamblin G (2003) The glycosylation of airway mucins in
cystic fibrosis and its relationship with lung infection by Pseudomonas
aeruginosa. Adv Exp Med Biol 535: 17-32. doi:
10.1007/978-1-4615-0065-0_2. PubMed: 14714886.
21. Atkinson GC, Baldauf SL (2011) Evolution of elongation factor G and
the origins of mitochondrial and chloroplast forms. Mol Biol Evol 28:
1281-1292. doi:10.1093/molbev/msq316. PubMed: 21097998.
22. Tam MF, Dodd JA, Hill WE (1981) Physical characteristics of 16 S
rRNA under reconstitution conditions. J Biol Chem 256: 6430-6434.
PubMed: 6165717.
23. Bradford MM (1976) A rapid and sensitive method for the quantitation
of microgram quantities of protein utilizing the principle of protein-dye
binding. Anal Biochem 72: 248-254. doi:
10.1016/0003-2697(76)90527-3. PubMed: 942051.
24. Cull MG, McHenry CS (1995) Purification of Escherichia coli DNA
polymerase III holoenzyme. Methods Enzymol 262: 22-35. doi:
10.1016/0076-6879(95)62005-2. PubMed: 8594350.
25. Bullard JM, Williams JC, Acker WK, Jacobi C, Janjic N et al. (2002)
DNA polymerase III holoenzyme from Thermus thermophilus
identification, expression, purification of components, and use to
Two Forms of EF-G from Pseudomonas aeruginosa
PLOS ONE | www.plosone.org 11 November 2013 | Volume 8 | Issue 11 | e80252
reconstitute a processive replicase. J Biol Chem 277: 13401-13408.
doi:10.1074/jbc.M110833200. PubMed: 11823461.
26. Nyfeler B, Hoepfner D, Palestrant D, Kirby CA, Whitehead L et al.
(2012) Identification of elongation factor G as the conserved cellular
target of argyrin B. PLOS ONE. 7: e42657. doi:10.1371/journal.pone.
0042657. PubMed: 22970117.
27. Jurnak F (1994) The ABC of EF-G. Structure. 2: 785-788. doi:10.1016/
S0969-2126(94)00078-6. PubMed: 7812711.
28. Nechifor R, Murataliev M, Wilson KS (2007) Functional interactions
between the G' subdomain of bacterial translation factor EF-G and
ribosomal protein L7/L12. J Biol Chem 282: 36998-37005. doi:10.1074/
jbc.M707179200. PubMed: 17932030.
29. Bodley JW, Zieve FJ, Lin L, Zieve ST (1969) Formation of the
ribosome-G factor-GDP complex in the presence of fusidic acid.
Biochem Biophys Res Commun 37: 437-443. doi:
10.1016/0006-291X(69)90934-6. PubMed: 4900137.
30. Gao YG, Selmer M, Dunham CM, Weixlbaumer A, Kelley AC et al.
(2009) The structure of the ribosome with elongation factor G trapped
in the post-translocational state. Science 326: 694-699. doi:10.1126/
science.1179709. PubMed: 19833919.
31. Martemyanov KA, Liljas A, Yarunin AS, Gudkov AT (2001) Mutations in
the G-domain of elongation factor G from Thermus thermophilus affect
both its interaction with GTP and fusidic acid. J Biol Chem 276:
28774-28778. doi:10.1074/jbc.M102023200. PubMed: 11371559.
32. Hansson S, Singh R, Gudkov AT, Liljas A, Logan DT (2005) Structural
insights into fusidic acid resistance and sensitivity in EF-G. J Mol Biol
348: 939-949. doi:10.1016/j.jmb.2005.02.066. PubMed: 15843024.
33. Johanson U, Hughes D (1994) Fusidic acid-resistant mutants define
three regions in elongation factor G of Salmonella typhimurium. Gene
143: 55-59. doi:10.1016/0378-1119(94)90604-1. PubMed: 7515367.
34. Chen Y, Koripella RK, Sanyal S, Selmer M (2010) Staphylococcus
aureus elongation factor G--structure and analysis of a target for fusidic
acid. FEBS J 277: 3789-3803. doi:10.1111/j.1742-4658.2010.07780.x.
PubMed: 20718859.
35. Palmer SO, Rangel EY, Montalvo AE, Tran AT, Ferguson KC et al.
(2013) Cloning and characterization of EF-Tu and EF-Ts from
Pseudomonas aeruginosa. Biomed Res International 2013: Article ID
585748 doi:10.1155/2013/585748. PubMed: 23984384.
36. Mosteller RC, Culp WJ, Hardesty B (1968) The requirement for tRNA
for the shift in the optimum Mg ++ concentration during the synthesis of
polyphenylalanine. Biochem Biophys Res Commun 30: 631-636. doi:
10.1016/0006-291X(68)90559-7. PubMed: 5642381.
37. Ribble W, Hill WE, Ochsner UA, Jarvis TC, Guiles JW et al. (2010)
Discovery and analysis of 4H-pyridopyrimidines, a class of selective
bacterial protein synthesis inhibitors. Antimicrob Agents Chemother 54:
4648-4657. doi:10.1128/AAC.00638-10. PubMed: 20696870.
38. Margus T, Remm M, Tenson T (2011) A computational study of
elongation factor G (EFG) duplicated genes: diverged nature underlying
the innovation on the same structural template. PLOS ONE 6: e22789.
doi:10.1371/journal.pone.0022789. PubMed: 21829651.
39. Bielecki P, Lukat P, Hüsecken K, Dötsch A, Steinmetz H et al. (2012)
Mutation in elongation factor G confers resistance to the antibiotic
argyrin in the opportunistic pathogen Pseudomonas aeruginosa.
Chembiochem 13: 2339-2345. doi:10.1002/cbic.201200479. PubMed:
23011873.
40. An D, Parsek MR (2007) The promise and peril of transcriptional
profiling in biofilm communities. Curr Opin Microbiol 10: 292-296. doi:
10.1016/j.mib.2007.05.011. PubMed: 17573234.
41. Moreau-Marquis S, Stanton BA, O'Toole GA (2008) Pseudomonas
aeruginosa biofilm formation in the cystic fibrosis airway. Pulm
Pharmacol Ther 21: 595-599. doi:10.1016/j.pupt.2007.12.001. PubMed:
18234534.
Two Forms of EF-G from Pseudomonas aeruginosa
PLOS ONE | www.plosone.org 12 November 2013 | Volume 8 | Issue 11 | e80252
